Abiopharma

Krystal Biotech to Present at Cantor Global Healthcare Conference 2025

Twist Bioscience Collaborates with Synthetic Design Lab

vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund

4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness

Silence Therapeutics - Silence Therapeutics to Participate in September Investor Conferences

New Form 144 - Adaptimmune Therapeutics PLC Filed: 2025-09-02 AccNo: 0001104659-25-086007 Size: 5 KB

New Form 8-K - ETHZilla Corp Filed: 2025-09-02 AccNo: 0001213900-25-082917 Size: 308 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13D/A - STAAR SURGICAL CO Filed: 2025-09-02 AccNo: 0000919574-25-005433 Size: 33 KB

New Form 8-K - IRADIMED CORP Filed: 2025-09-02 AccNo: 0001558370-25-011834 Size: 184 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - FIBROGEN INC Filed: 2025-09-02 AccNo: 0000950170-25-112341 Size: 182 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Thermo Fisher Scientific - Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business

Nkarta to Participate in a September Investor Conference

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Agilent Technologies, Inc. - Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer